Header Background

1L aRCC - Changing the Treatment Paradigm

IO+Anti-VEGF Combinations

AGENDA

Event Moderator: Dr. Daniel Keizman

  • 17:00-17:30 Gathering & refreshments
  • 17:30-18:00 Rationalizing the combination of angiogenesis inhibitors with PD-1 blockade
    Prof. Gal Markel
  • 18:00-18:40 IO+Anti-VEGF therapy in 1L aRCC - Current and future perspectives
    Brian Rini, MD. FACP
  • 18:40-19:20 Case presentation and patient management in IO+Anti-VEGF therapy
    Brian Rini, MD. FACP
  • 19:20-20:00 Q&A with Dr. Brian Rini & Prof. Gal Markel
  • 20:00 Dinner

Please select 1-2 topics that interest you the most: